PROCEPT BioRobotics Reports Third Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
REDWOOD CITY, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) — PROCEPT® BioRobotics Corporation (Nasdaq: PRCT) (the…
Month: November 2022
Denali Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (Nasdaq: DNLI),…
Freeline Reports October 2022 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
LONDON, Nov. 03, 2022 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced…
Apellis Announces Plans to Submit 24-Month Phase 3 Data to the FDA for Pegcetacoplan NDA for Geographic Atrophy (GA)
Inclusion of the 24-month data has the potential to strengthen the product profile at launch,…
MacroGenics Provides Corporate Update and Third Quarter 2022 Financial Results
Collaboration with Gilead to develop bispecific antibodies, including MGD024, announced Planned initiation of Phase 2…
Capricor Therapeutics to Present Third Quarter 2022 Financial Results and Recent Corporate Update on November 10
Company to Host Conference Call, November 10, 2022, at 4:30 p.m. ET SAN DIEGO, Nov….
Codiak BioSciences Reports Third Quarter 2022 Financial Results and Operational Progress
– Patient enrollment continuing in Phase 1 clinical trial of exoASO™-STAT6 in patients with advanced…
BioAtla Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
Mecbotamab vedotin (BA3011) Phase 2 part 1 interim results in NSCLC continue to show antitumor…
Fate Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Operational Progress
FT596+R Enrollment Ongoing in Three-dose Escalation Cohort for R/R BCL; Activating Community Sites for Investigation…
Collegium Reports Third Quarter 2022 Financial Results
– Generated Record Net Revenue of $127.0 Million – – Completed Xtampza® ER Contract Renegotiations,…
Iovance Biotherapeutics Reports Third Quarter and Year-to-Date 2022 Financial Results and Corporate Updates
First Biologics License Application (BLA) Submission Initiated and on Track to Complete in 4Q22 SAN…
Oncternal Therapeutics Provides Business Update and Announces Third Quarter 2022 Financial Results
Initiated Phase 3 global registrational Study ZILO-301 of our zilovertamab product candidate targeting ROR1 in…
Ventyx Biosciences Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress
We are on track to initiate Phase 2 trials of our allosteric TYK2 inhibitor VTX958…
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
Clear path forward for accelerated growth and value creation Reshape innovation model and build fit-for-purpose…
Nimrod Lehavi, the Founder of Simplex, Joins Locus Chain as an Advisor
Locus Chain is a distributed data-storing system where the participators can freely add data. Recently,…
Sebastian Borget, COO of The Sandbox Gaming Virtual World, Is Awarded ‘Leader on Tourism’ by World Tourism Forum Institute
Paris, France–(Newsfile Corp. – November 3, 2022) – Bulut BAĞCI, the President of World Tourism…
Gatik Named to FreightWaves’ 2023 FreightTech 25 List
Company recognized for historic technical achievements in supply chain innovation and commercial application of autonomous…
KBRA Assigns Preliminary Ratings to SCF Equipment Leasing 2022-2
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to nine classes of notes issued by SCF Equipment…
Flowserve Chief Executive Officer Scott Rowe to Present at the 52nd Annual Baird Global Industrial Conference
DALLAS–(BUSINESS WIRE)–Flowserve Corporation (NYSE: FLS), a leading provider of flow control products and services for…
Sungard AS Successfully Completes Transactions with 11:11 Systems and 365 Data Centers
WAYNE, Pa.–(BUSINESS WIRE)–Sungard Availability Services (“Sungard AS”) today announced the successful completion of the previously…